🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A clinical study of lurbinectedin(PM01183) alone or in combination with gem...
Status
Completed
Location
Multiple Locations
Start Date
2013-09-11
Trial ID
NCT01951157
Treatments Being Tested
This is a multi-center, multi-arm open-label phase Ib/II clinical study ass...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-10-31
Trial ID
NCT06217536
Treatments Being Tested
This is a phase I, multicenter, open-label, dose escalating clinical and ph...
Status
Completed
Location
Cancer Research Center. University of Chicago Hospitals.
Start Date
2009-03
Trial ID
NCT00877474
Treatments Being Tested
This research study involves the study drug lurbinectedin in combination wi...
Status
Active Not Recruiting
Location
Mayo Arizona
Start Date
2022-02-04
Trial ID
NCT05099666
Treatments Being Tested
This exploratory trial aims to determine if it is safe to use radiotherapy ...
Status
Active Not Recruiting
Location
National Cancer Center/Cancer Hospital
Start Date
2025-12-31
Trial ID
NCT06501976
Treatments Being Tested
Study to assess the potential effects of lurbinectedin (PM01183) at a thera...
Status
Completed
Location
Sarcoma Oncology Research Center
Start Date
2015-08-12
Trial ID
NCT02451007
Treatments Being Tested
Phase I multicenter, open-label, clinical and pharmacokinetic study of PM01...
Status
Completed
Location
Hospital Universitario Madrid Sanchinarro
Start Date
2011-05
Trial ID
NCT01970553
Treatments Being Tested
The purpose of this study is to find out if a drug called lurbinectedin (th...
Status
Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2023-07-27
Trial ID
NCT05918640
Treatments Being Tested
This is a single-arm, open-lable exploratory study of Lurbinectedin in comb...
Status
Recruiting
Location
The first affiliated hospital of Guangzhou medical university
Start Date
2024-12-01
Trial ID
NCT06497530
Treatments Being Tested
The goal of this clinical study is to learn more about the study drug sacit...
Status
Recruiting
Location
Alaska Oncology and Hematology
Start Date
2025-04-04
Trial ID
NCT06801834